No results found for the specified company. What industry related changes do you ... Alexion Pharmaceuticals Examples

MockQuestions

Alexion Pharmaceuticals Mock Interview

Question 4 of 29 for our Alexion Pharmaceuticals Mock Interview

Get More Information About Our Alexion Pharmaceuticals Interview Questions

Question 4 of 29

What industry related changes do you foresee in the next 12 months?

"I read on your website that Alexion Pharmaceuticals is expected to see a 43% increase in the sales of product ABC. This fact piqued my interest as I have seen reports that forecast a strong increase in the use of product ABC for alternative medical therapies. There are continual changes in this industry, but I see this particular one being very significant in the upcoming months."

Next Question

How to Answer: What industry related changes do you foresee in the next 12 months?

Advice and answer examples written specifically for an Alexion Pharmaceuticals job interview.

  • 4. What industry related changes do you foresee in the next 12 months?

      How to Answer

      Assure the interviewer that you have a keen and honest interest in this industry by discussing the growth and change that you foresee in this next year. If the organization itself has any upcoming news or changes, be sure to mention these as well.

      1st Answer Example

      "I read on your website that Alexion Pharmaceuticals is expected to see a 43% increase in the sales of product ABC. This fact piqued my interest as I have seen reports that forecast a strong increase in the use of product ABC for alternative medical therapies. There are continual changes in this industry, but I see this particular one being very significant in the upcoming months."

      2nd Answer Example

      "I was recently reading an article by Q1 Productions that addressed this exact topic. They mentioned in the article that 2018 is going to be a great year for the pharma industry due to the economic upturn. The thought is that this will increase stock prices; thus, allowing pharma companies to grow their offerings, expand operations, and further their research and reach. It's an exciting thought!"